Clinical Trial Detail

NCT ID NCT01526837
Title Bevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First Recurrence
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Brain & Spine Surgeons of New York
Indications

glioblastoma multiforme

Therapies

Bevacizumab

Age Groups: adult

No variant requirements are available.